サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587818

血液スクリーニングの市場規模、シェア、動向分析レポート：技術別、製品別、地域別、セグメント予測、2025年～2030年

Blood Screening Market Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血液スクリーニングの市場規模、シェア、動向分析レポート：技術別、製品別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月21日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液スクリーニング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血液スクリーニング市場規模は、2025年から2030年にかけてCAGR 11.9％を記録し、2030年までに66億2,000万米ドルに達する見込みです。

同市場の成長は、ドナーのスクリーニングの増加と市場参入企業による継続的な技術進歩に起因しています。血液スクリーニング検査の需要は、献血の増加、輸血感染症に対する意識の高まり、業界の技術開発により継続的に増加しています。さらに、さまざまな国の政府が、すべての献血血液をいくつかのウイルスについて検査することを義務付けています。

レシピエントが最も安全な血液製剤を受け取れるようにするためには、すべての献血血液に対して徹底的なスクリーニングが必要です。2015年現在、このような検査は、赤血球抗体と感染症病原体のスクリーニングで構成されている：HIV-1、HIV-2、肝炎ウイルス、ウエストナイルウイルス（WNV）、ヒトTリンパ向性ウイルス（HTLV）、T. Cruzi、T. pallidum（梅毒）。これらの検査結果がすべて陰性であることが献血の条件です。

技術開発により、検査の感度と効率は向上しています。例えば、2016年、米国FDAは、献血血液をスクリーニングするために、Hologic, Inc.とGrifolsのProcleixジカウイルスアッセイを承認しました。さらに、米国FDAは2013年に次世代シーケンス（NGS）技術を承認しました。この技術は従来のDNA分析法よりも安価で迅速です。

血液スクリーニング市場レポートハイライト

  • 核酸増幅検査（NAT）が市場を独占し、2024年には41.2%の最大収益シェアを占めました。HIVや肝炎などの感染症の流行が増加し、NAATが提供する正確で迅速な検査法が必要とされているためです。
  • 次世代シーケンシング（NGS）は予測期間中にCAGR 16.5％で成長する見込みです。この技術は、精度を向上させながらシーケンスコストを大幅に削減することで、ゲノム解析に革命をもたらしました。
  • 試薬は市場をリードし、2024年には最大の売上シェア73.4%を占めました。試薬は診断検査に不可欠なコンポーネントであり、正確な結果を得るために特定の反応を引き出すために必要な化学的、生物学的、免疫学的物質を提供します。
  • 機器は、技術的進歩と効果的な診断ソリューションに対する需要の増加により、予測期間中最も速いCAGR 10.8％で成長する見込みです。
  • 北米の血液スクリーニング市場は世界市場を独占し、2024年には38.4％の最大収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血液スクリーニング市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 血液スクリーニング市場：技術ビジネス分析

  • 技術市場シェア、2024年と2030年
  • 技術セグメントダッシュボード
  • 市場規模と予測および動向分析、技術別、2018～2030年
  • 核酸増幅検査（NAT）
  • ELISA
  • 化学発光免疫測定法（CLIA &EIA）
  • 次世代シーケンシング（NGS）
  • ウエスタンブロッティング（WB）

第5章 血液スクリーニング市場：製品ビジネス分析

  • 製品市場シェア、2024年および2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測および動向分析、製品別、2018～2030年
  • 試薬
  • 機器

第6章 血液スクリーニング市場：地域推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル
    • Abbott
    • Danaher Corporation（Beckman Coulter）
    • Becton Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Grifols, SA
    • Ortho-Clinical Diagnostics, Inc.
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific, Inc.
    • SOFINA sa（Biomerieux）
図表

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Blood Screening Market, by Region, 2018-2030 (USD Million)
  • Table 4. Global Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5. Global Blood Screening Market, by Product, 2018-2030 (USD Million)
  • Table 6. North America Blood Screening Market, by Country, 2018-2030 (USD Million)
  • Table 7. North America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 8. North America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10. U.S. Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. Canada Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. Canada Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. Mexico Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14. Mexico Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Europe Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 17. Europe Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. UK Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19. UK Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 20. Germany Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21. Germany Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. France Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23. France Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 24. Italy Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25. Italy Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 26. Spain Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27. Spain Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Norway Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Norway Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 30. Denmark Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31. Denmark Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Sweden Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Sweden Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Japan Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38. Japan Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 39. China Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40. China Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 41. India Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42. India Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Australia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44. Australia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 45. South Korea Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46. South Korea Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Thailand Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48. Thailand Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 49. Latin America Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51. Latin America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Brazil Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Brazil Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Argentina Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55. Argentina Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 59. South Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60. South Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 63. UAE Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64. UAE Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Blood Screening Market, by Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Blood Screening Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot

Fig. 9 Product, and Technology Outlook (USD Million)

  • Fig. 10 Product, and Technology Outlook
  • Fig. 11 Competitive Landscape
  • Fig. 12 Blood Screening Market Dynamics
  • Fig. 13 Blood Screening Market: Porter's Five Forces Analysis
  • Fig. 14 Blood Screening Market: PESTLE Analysis
  • Fig. 15 Blood Screening Market: Technology Segment Dashboard
  • Fig. 16 Blood Screening Market: Technology Market Share Analysis, 2024 & 2030
  • Fig. 17 Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • Fig. 18 ELISA Market, 2018 - 2030 (USD Million)
  • Fig. 19 Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • Fig. 20 Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • Fig. 21 Western Blotting (WB) Market, 2018 - 2030 (USD Million)
  • Fig. 22 Blood Screening Market: Product Segment Dashboard
  • Fig. 23 Blood Screening Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 24 Reagent Market, 2018 - 2030 (USD Million)
  • Fig. 25 Instrument Market, 2018 - 2030 (USD Million)
  • Fig. 26 Blood Screening Market Revenue, by Region
  • Fig. 27 Regional marketplace: Key Takeaways
  • Fig. 28 Regional marketplace: Key Takeaways
  • Fig. 29 North America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Country Dynamics
  • Fig. 31 U.S. Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Country Dynamics
  • Fig. 33 Canada Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Country Dynamics
  • Fig. 35 Mexico Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Country Dynamics
  • Fig. 38 UK Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Country Dynamics
  • Fig. 40 Germany Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 41 France Country Dynamics
  • Fig. 42 France Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Country Dynamics
  • Fig. 44 Italy Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Country Dynamics
  • Fig. 46 Spain Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Country Dynamics
  • Fig. 48 Norway Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Country Dynamics
  • Fig. 50 Sweden Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark Country Dynamics
  • Fig. 52 Denmark Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Country Dynamics
  • Fig. 55 Japan Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 56 China Country Dynamics
  • Fig. 57 China Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 58 India Country Dynamics
  • Fig. 59 India Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Country Dynamics
  • Fig. 61 Australia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Country Dynamics
  • Fig. 63 South Korea Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Country Dynamics
  • Fig. 65 Thailand Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Country Dynamics
  • Fig. 68 Brazil Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina Country Dynamics
  • Fig. 70 Argentina Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa Country Dynamics
  • Fig. 73 South Africa Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia Country Dynamics
  • Fig. 75 Saudi Arabia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE Country Dynamics
  • Fig. 77 UAE Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait Key Country Dynamics
  • Fig. 79 Kuwait Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 80 Company Categorization
  • Fig. 81 Company Market Position Analysis
  • Fig. 82 Strategic Framework
目次
Product Code: GVR-1-68038-215-0

Blood Screening Market Growth & Trends:

The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.

Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Blood Screening Market Report Highlights:

  • Nucleic acid amplification tests (NAT) dominated the market and accounted for the largest revenue share of 41.2% in 2024 attributed to the increasing prevalence of infectious diseases, such as HIV and hepatitis, necessitating accurate and rapid testing methods that NAATs provide.
  • Next Generation Sequencing (NGS) is expected to grow at a CAGR of 16.5% over the forecast period. The technology has revolutionized genomic analysis by significantly reducing sequencing costs while improving accuracy.
  • Reagents led the market and accounted for the largest revenue share of 73.4% in 2024. Reagents are essential components in diagnostic tests, providing the necessary chemical, biological, or immunological substances to elicit specific reactions for accurate results.
  • Instruments are expected to grow at the fastest CAGR of 10.8% over the forecast period, owing to technological advancements and increasing demand for effective diagnostic solutions.
  • North America blood screening market dominated the global market and accounted for the largest revenue share of 38.4% in 2024 attributed to advanced healthcare infrastructure and a strong emphasis on patient safety.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Blood Screening Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Nucleic Acid Amplification Test (NAT)
    • 4.4.1. Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • 4.5. ELISA
    • 4.5.1. ELISA Market, 2018 - 2030 (USD Million)
  • 4.6. Chemiluminescence Immunoassay (CLIA & EIA )
    • 4.6.1. Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • 4.7. Next Generation Sequencing (NGS)
    • 4.7.1. Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • 4.8. Western Blotting (WB)
    • 4.8.1. Western Blotting (WB) Market, 2018 - 2030 (USD Million)

Chapter 5. Blood Screening Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Reagent
    • 5.4.1. Reagent Market, 2018 - 2030 (USD Million)
  • 5.5. Instrument
    • 5.5.1. Instrument Market, 2018 - 2030 (USD Million)

Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Danaher Corporation (Beckman Coulter)
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Becton Dickinson and Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hoffman-La Roche Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Grifols, S.A.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Ortho-Clinical Diagnostics, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Siemens Healthcare GmbH
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Thermo Fisher Scientific, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. SOFINA s.a (Biomerieux)
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives